Neuraminidase treatment of cells infected with herpes simplex virus type 1 (HSV-1) markedly enhanced the binding of complement component C3b to HSV 1 glycoprotein C (gC). When HSV-1 was grown in BHK RicR14 cells in which glycoproteins had reduced amounts of N-linked complex oligosaccharides, including sialic acid, the binding of C3b to gC was markedly enhanced. We used neuraminidase treatment to demonstrate that cloning the gC gene from the HSV-1 F strain into an HSV-1 mutant which fails to express gC converted the mutant virus from C3b receptor negative to receptor positive. These results further support a role for gC as a C3b receptor and indicate that sialic acid modifies receptor activity. Posttranslational processing of gC involves the addition of sialic acid to the precursor form of the glycoprotein (3). Sialic acid is important in the regulation of complement activation (11, 14, 22) and is known to modify the binding of immunoglobulin G (IgG) to HSV-1-induced Fc receptors (4, 19) and to Fc receptors present on T lymphocytes (24). In this study, we evaluate the role of sialic acid on gC in modifying the binding of C3b to the viral receptor.
Herpes simplex virus type 1 (HSV-1) induces a receptor for the third component of complement on the plasma membrane of infected cells (2) . The binding of complement component of C3b to this receptor is blocked by monoclonal antibody to HSV-1 glycoprotein C (gC) but not by monoclonal antibodies to HSV-1 gB, gD, or gE, (8) . No C3b receptors are expressed after infection with the HSV-1 MP virus (8) , a mutant which fails to express gC on infected cells (10, 18) .
Posttranslational processing of gC involves the addition of sialic acid to the precursor form of the glycoprotein (3) . Sialic acid is important in the regulation of complement activation (11, 14, 22) and is known to modify the binding of immunoglobulin G (IgG) to HSV-1-induced Fc receptors (4, 19) and to Fc receptors present on T lymphocytes (24) . In this study, we evaluate the role of sialic acid on gC in modifying the binding of C3b to the viral receptor.
Human endothelial cells were harvested from umbilical veins and cultured on fibronectin-coated wells as previously described (5, 8, 16, 17) . C3b receptors were detected 20 h after HSV-1 infection (NS strain) (9) by erythrocyte rosetting and by binding assays with 51Cr-labeled erythrocytes (8) . Complement-coated erythrocytes were incubated with the monolayer for 2 h at 37°C, unbound erythrocytes were removed by washing, and monolayers were observed for rosettes. To determine the percentage of 51Cr binding, adherent erythrocytes were lysed with distilled water, and the release of 5"Cr was measured. Blocking experiments were performed by incubating the monolayers with monoclonal antibody to HSV-1 gC for 30 min before the addition of erythrocytes (8) To determine the optimal concentration of neuran various amounts of enzyme (0.02, 0.05, 0.10, and were added to the monolayer in 0.2-ml volumes for Even at the lowest concentrations examined (0.C marked increase in the binding of 51Cr-labeled E cells was detected. Higher concentrations increr binding of EAC1423 cells only slightly.
We examined the expression of C3b receptors and BHK RicR14 cells (kindly provided by R. C. London, England). The latter were evaluated to support a role for sialic acid in modulating receptor f BHK RicR14 cells are mutant BHK cells deficiei acetyl glucosaminyl transferase 1, an essential enzyr assembly of complex N-linked oliogosaccharides 27). In HSV-1-infected BHK RicR14 cells, truncat4 of viral N-linked glycoproteins with reduced am N-acetyl glucosamine, galactose, and sialic acid acc on the infected cell surface. In spite of the differ glycosylation, HSV-1 replicates in BHK RicR14 yields similar to those in parental BHK cells (1 HSV-1 F strain. The parental source of gC, the HSV-1 F strain, expressed C3b receptors which were enhanced by neuraminidase treatment and blocked by monoclonal antibody to gC (Fig. 4a) . Human endothelial cells infected with MP did not express C3b receptors either with or without neuraminidase treatment (Fig. 4b) . After infection by MP 6-9A, rosetting of EAC1423 cells was detected around 5 to 10% of endothelial cells. Anti-gC monoclonal antibody reduced rosetting to <1%, indicating specific binding. By the 5tCr assay, binding of EAC1423 cells to MP 6-9A-infected cells was 5.0 + 2.9% (Fig. 4c) (Fig. 4c, t by anti-gC monoclonal antibody and were totally blocked by anti-gC polyclonal serum (Fig. 4c) . These (6, 7, 13) . If (15) . Receptor detection is partially blocked by anti-gC monoclonal antibody and totally blocked by anti-gC polyclonal serum.
HSV-proteins have been reported (23) ; therefore, even the same strain of HSV-1 may vary in the extent to which it expresses C3b receptors, depending on which organ or cell type is infected. These differences may be important causes of variations in strain virulence or in understanding the propensity for HSV-1 to cause disease in particular body organs.
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